The disposition of nitrofurazone was studied in the isolated perfused rat liver using a recirculating system. The drug was administered as a bolus in two different doses (3.5 and 14 mg: initial concentrations 0.35 and 1.4mM respectively), and its disappearance was monitored by analyzing perfusate samples at various times. Biliary excretion and bile flow were also measured. In all experiments perfusate disappearance was monoexponential, and no significant difference was found between the two doses (T1 2: 5.34 ± 2.03 and 6.19 ± 1.47 min for 14 and 3.5 mg respectively). Bile flow increased more than 2-fold 5-10 min after administration of the drug and subsequently returned to control levels. The increase in bile flow was dose-related and paralleled the excretion of the parent drug in the bile; however, of the total dose administered, only 0.27 ± 0.04% was excreted unchanged in bile, thus ruling out an osmotic choleresis due to the parent drug. Since nitrofurazone may be excreted in part as a glutathione conjugate, this or other metabolites could have caused an osmotic choleresis. This hypothesis was tested by administering diethylmaleate which causes glutathione depletion. Although the initial bile flow in treated livers was not different from untreated livers, bile flow did not increase after administration of nitrofurazone. In addition, the perfusate half-life of nitrofurazone was increased (18.18 ± 1.30 min, P < 0.005). These results suggest that nitrofurazone is cleared rapidly by the liver and that glutathione plays an important role in its disposition
